Showing results (91-100 of 224) with videos related to

Sort By:
Pageof 23
International Journal of Pharmaceutics|April 3, 2020
Brain accumulation of tivozanib is restricted by ABCB1 (P-glycoprotein) and ABCG2 (breast cancer resistance protein) in miceJing Wang, Maaike A C Bruin, Changpei Gan, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 3, 2024
ELISA assay for the quantification of ipilimumab in human serum, plasma, milk, and cerebrospinal fluidDick Pluim, Pauline Buitelaar, Karen A M de Jong, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 22, 2016
Metabolite profiling of 14C-omacetaxine mepesuccinate in plasma and excreta of cancer patientsCynthia M Nijenhuis, Luc Lucas, Hilde Rosing, et al.
Cancer Chemotherapy and Pharmacology|April 25, 2022
Comparison of docetaxel pharmacokinetics between castration-resistant and hormone-sensitive metastatic prostate cancer patientsMarit A C Vermunt, Merel van Nuland, Lisa T van der Heijden, et al.
Future Oncology (London, England)|March 4, 2020
Vorinostat in patients with resistant BRAF mutated advanced melanoma: a proof of concept studySanne Huijberts, Liqin Wang, Rodrigo Leite de Oliveira, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 8, 2008
Development and validation of a quantitative assay for the measurement of miltefosine in human plasma by liquid chromatography-tandem mass spectrometryThomas P C Dorlo, Michel J X Hillebrand, Hilde Rosing, et al.
International Journal of Cancer|October 24, 2012
P-glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxelJeroen J M A Hendrikx, Jurjen S Lagas, Hilde Rosing, et al.
Pageof 23